|
|
|
|
|
|
|
18.04.26 - 05:00
|
As China′s biotech firms shift gears, can AI floor the accelerator? (SCMP)
|
|
|
A quarter featuring multiple eye-popping deals is no longer unusual for China's pharmaceutical industry – in fact, it may soon be considered a slow season.
In recent months, companies including CSPC Pharmaceutical and RemeGen have struck out-licensing agreements worth up to US$18.5 billion and US$5.6 billion respectively, while Haisco Pharmaceutical Group has added two of its own — most recently a deal worth up to US$745 million.
Under the terms of the deal, the Beijing-based Haisco granted US......
|
|
|
|
|
|
|
|
|
|
|
|
|
17.04.26 - 13:31
|
Abspaltung der Siemens-Medizintechnik erst im Jahr 2027 (Dow Jones)
|
|
|
DOW JONES--Die Abspaltung der Siemens-Medizintechnik vom Mutterkonzern wird erst im nächsten Jahr stattfinden. Die Siemens-Aktionäre sollen darüber auf der ordentlichen Siemens-Hauptversammlung im Februar 2027 abstimmen, wie der Technologiekonzern mitteilte. ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|